In 2022, Mark Cuban launched Cost Plus Drugs to make pharmaceuticals more affordable for everyone, aiming to reduce healthcare costs and take on the healthcare industry. His critiques of pharmacy benefit managers (PBMs) have intensified, as they are seen as cash cows inflating drug prices. Cuban’s solution is to negotiate directly with manufacturers, cutting out PBMs and reducing costs. Meanwhile, hospital administrators have grown 3,200% since 1970, contributing to rising healthcare costs. Cuban advocates for reform, suggesting divesting non-insurance assets from PBMs to lower costs for patients. This shift poses a threat to high-margin healthcare services.

Read more at Barchart: Is Divestiture the Only Cure for the 3,200% Admin Bubble?